NOS1 and ischemic stroke: These findings will clarify the competitive interplay between CaM allosteric activation and SUMO1 modification in nNOS hyperactivity, providing structural insights for designing targeted inhibitors to mitigate neurotoxicity in ischemic stroke and related disorders, ultimately advancing novel therapeutic strategies.